Fredun Pharmaceuticals Ltd.

850.00 -9.20 ▼-1.1%

08 December 2023, 04:01:00 PM
Volume: 7,893

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fredungroup.com
Market Cap 393.98 Cr.
Enterprise Value(EV) 462.46 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 29.13 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 28.78 Trailing Twelve Months Ending 2023-09
Industry PE 38.54 Trailing Twelve Months Ending 2023-09
Book Value / Share 239.68 Trailing Twelve Months Ending 2023-09
Price to Book Value 3.50 Calculated using Price: 838.40
Dividend Yield 0.08 Period Ending 2023-03
No. of Shares Subscribed 0.47 Cr. 4,699,162 Shares
FaceValue 10
About Fredun Pharmaceuticals Ltd.
The company is engaged in manufacturing of pharmaceutical products.

Fredun Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Fredun Pharmaceuticals Ltd. Performance

1 Day
-1.07%
1 Week
-4.82%
1 Month
-4.67%
3 Month
-6.86%
6 Month
+1.00%
1 Year
-38.58%
2 Year
+69.68%
5 Year
+160.74%
10 Year

Fredun Pharmaceuticals Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 9.68 33.46 33.88 13.02 14.59 4.74 4.77 11.42 13.86
Return on Capital Employed (%) 14.23 24.67 18.16 15.90 20.56 10.36 9.53 13.15 18.35
Return on Assets (%) 1.26 3.23 2.88 2.59 4.84 1.54 1.33 3.63 4.86

Fredun Pharmaceuticals Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3 4 7 22 39 41 43 68 96 111
Non Curr. Liab. 4 7 8 4 13 14 32 45 55 20
Curr. Liab. 16 32 40 53 53 86 86 74 106 147
Minority Int.
Equity & Liab. 23 43 56 79 105 141 162 187 257 279
Non Curr. Assets 10 15 21 28 32 32 32 34 41 45
Curr. Assets 13 28 35 51 73 109 130 153 216 234
Misc. Exp. not W/O 0
Total Assets 23 43 56 79 105 141 162 187 257 279

Fredun Pharmaceuticals Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 25 42 57 60 97 113 134 224 275 302
Other Income 0 1 2 0 1 1 1 2 2
Total Income 26 43 59 60 98 113 135 226 277 302
Total Expenditure -24 -38 -53 -54 -87 -104 -125 -211 -246 -265
PBIDT 2 5 5 6 11 9 11 16 31 37
Interest -1 -2 -2 -2 -3 -4 -4 -5 -10 -11
Depreciation -1 -1 -1 -1 -1 -2 -2 -2 -3 -3
Taxation 0 -1 -1 -1 -2 -1 -1 -2 -7 -9
Exceptional Items 0 0 -1
PAT 0 1 1 2 4 2 2 6 11 14
Adjusted EPS 1 4 5 4 11 5 5 14 24 30

Fredun Pharmaceuticals Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 2 3 4 17 1 -11 0 -2 -14
Cash Fr. Inv. -2 -3 -6 -7 -8 -5 -1 -1 -4 -9
Cash Fr. Finan. 2 1 3 3 -8 4 14 -1 7 25
Net Change 0 0 1 -1 1 0 2 -2 1 1
Cash & Cash Eqvt 0 1 1 1 1 1 3 1 2 3

Fredun Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 52.04 51.27 51.27 51.04 51.04 50.34 50.15 49.62 49.31
Public 47.96 48.73 48.73 48.96 48.96 49.66 49.85 50.38 50.69
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 5.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Fredun Pharmaceuticals Ltd. Announcements

Fri, 08 Dec 2023
Board Meeting Intimation for Prior Intimation For Fund Raising
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/12/2023 inter alia to consider and approve for fund raising upto Rs. 120 crores by way of further public offer right issue ADR/GDR/FCCB QIP Debt issue preferential issue or any other method.
Thu, 07 Dec 2023
Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and Code of Conduct for Prevention of Insider Trading of Fredun Pharmaceuticals Ltd the trading window for dealing in securities of the Company will remain closed for designated persons and their immediative relatives with effect from December 07 2023 till 48 hours after the end of the Board Meeting wherein the approval for raising funds would be considered approved and declared. The said information is being notified to all designated persons under the above regulations.
Tue, 05 Dec 2023
Board Meeting Outcome for ALLOTMENT OF 5000 EQUITY SHARES TO NON-PROMOTER UPON CONVERSION OF WARRANTS INTO EQUITY SHARES
This is to inform you that the Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23 2022 has done allotment of convertible warrants on preferential basis to Promoters and Non-promoters on October 15 2022.Further we would like to inform that the Warrant Holder have paid the balance of the consideration aggregating to Rs. 24 90 500/- and have applied for exercising their rights for conversion of 5 000 warrants into equivalent number of Equity Shares.

Fredun Pharmaceuticals Ltd. Technical Scans

Fri, 08 Dec 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low

Fredun Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,403.90 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,685.46 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,584.38 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.50 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.25 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.16 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.96 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.26 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.37 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Fredun Pharmaceuticals Ltd. FAQ's

What is Fredun Pharma share price?

Can I buy Fredun Pharma shares now?

What is the Dividend Yield of Fredun Pharma?

What is the Market Cap of Fredun Pharma?

What are the key metrics to analyse Fredun Pharma?

What is the 52 Week High and Low of Fredun Pharma?

What is the trend of Fredun Pharma share price?